StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.81+0.03 (+0.63%)

Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%

Lifevantage net income

Net income is the profit left for shareholders after every expense, interest and tax.

Lifevantage's net income for the twelve months ending Jun 30, 2026 was $5.07M, down 48.3% year over year. For fiscal 2026 it was $5.07M, down 48.3% from the year before. Over ten years it grew -1.8% a year on average. The highest annual figure on record is $12.89M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2026Jun 30, 2026$5.07M-48.3%
FY2025Jun 30, 2025$9.81M+233.8%
FY2024Jun 30, 2024$2.94M+15.6%
FY2023Jun 30, 2023$2.54M-18.6%
FY2022Jun 30, 2022$3.12M-75.8%
FY2021Jun 30, 2021$12.89M+11.6%
FY2020Jun 30, 2020$11.55M+55.5%
FY2019Jun 30, 2019$7.43M+29.0%
FY2018Jun 30, 2018$5.76M+258.3%
FY2017Jun 30, 2017$1.61M-73.7%
FY2016Jun 30, 2016$6.11M-14.3%
FY2015Jun 30, 2015$7.13M-37.4%
FY2014Jun 30, 2014$11.38M+49.6%
FY2013Jun 30, 2013$7.61M-39.0%
FY2012Jun 30, 2012$12.47M–
FY2011Jun 30, 2011-$50.79M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$1.28M-34.7%
Q3 FY2026CQ1 2026Mar 31, 2026$1.36M-60.7%
Q2 FY2026CQ4 2025Dec 31, 2025$276.00K-89.2%
Q1 FY2026CQ3 2025Sep 30, 2025$2.16M+18.0%
Q4 FY2025CQ2 2025Jun 30, 2025$1.96M+50.1%
Q3 FY2025CQ1 2025Mar 31, 2025$3.47M+109.2%
Q2 FY2025CQ4 2024Dec 31, 2024$2.55M–
Q1 FY2025CQ3 2024Sep 30, 2024$1.83M+190.3%
Q4 FY2024CQ2 2024Jun 30, 2024$1.31M-33.6%
Q3 FY2024CQ1 2024Mar 31, 2024$1.66M+62.3%
Q2 FY2024CQ4 2023Dec 31, 2023-$656.00K–
Q1 FY2024CQ3 2023Sep 30, 2023$629.00K+3.1%
Q4 FY2023CQ2 2023Jun 30, 2023$1.97M–
Q3 FY2023CQ1 2023Mar 31, 2023$1.02M-10.4%
Q2 FY2023CQ4 2022Dec 31, 2022-$1.06M-1439.2%
Q1 FY2023CQ3 2022Sep 30, 2022$610.00K-81.6%
Q4 FY2022CQ2 2022Jun 30, 2022-$1.42M-128.9%
Q3 FY2022CQ1 2022Mar 31, 2022$1.14M-33.8%
Q2 FY2022CQ4 2021Dec 31, 2021$79.00K-97.9%
Q1 FY2022CQ3 2021Sep 30, 2021$3.32M+35.3%
Q4 FY2021CQ2 2021Jun 30, 2021$4.91M+28.3%
Q3 FY2021CQ1 2021Mar 31, 2021$1.72M+3.8%
Q2 FY2021CQ4 2020Dec 31, 2020$3.81M-11.4%
Q1 FY2021CQ3 2020Sep 30, 2020$2.45M+39.2%
Q4 FY2020CQ2 2020Jun 30, 2020$3.82M-2.1%
Q3 FY2020CQ1 2020Mar 31, 2020$1.66M-6.8%
Q2 FY2020CQ4 2019Dec 31, 2019$4.30M+419.1%
Q1 FY2020CQ3 2019Sep 30, 2019$1.76M+93.3%
Q4 FY2019CQ2 2019Jun 30, 2019$3.91M+30.6%
Q3 FY2019CQ1 2019Mar 31, 2019$1.78M+9.0%
Q2 FY2019CQ4 2018Dec 31, 2018$829.00K+161.5%
Q1 FY2019CQ3 2018Sep 30, 2018$911.00K+11.5%
Q4 FY2018CQ2 2018Jun 30, 2018$2.99M+3461.9%
Q3 FY2018CQ1 2018Mar 31, 2018$1.64M+2580.3%
Q2 FY2018CQ4 2017Dec 31, 2017$317.00K+12.0%
Q1 FY2018CQ3 2017Sep 30, 2017$817.00K-30.8%
Q4 FY2017CQ2 2017Jun 30, 2017$84.00K–
Q3 FY2017CQ1 2017Mar 31, 2017$61.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$283.00K–
Q1 FY2017CQ3 2016Sep 30, 2016$1.18M–

More Lifevantage figures

See a number that looks wrong?